PATENT CLAIM ANALYSIS

Application Number: 15764215
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-11
Patent Classification: ["514", "235800"]

Abstract:
The present invention provides the use of protein kinase inhibitors, in particular JAK2 inhibitors of formula (I), as set forth in the specification, in the treatment of solid organ transplant rejection and graft versus host disease (GvHD). Also provided are combination therapies for the treatment of solid organ transplant rejection and graft versus host disease.

Claim (Index 7):
The method according to  claim 1  wherein the compound of formula (I) has the formula: or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 90.0
- Lexical Diversity: 1.6
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14523650', '15586058', '11208046', '13640162', '10732429']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7677773521812623
- 35 USC 102 Novelty (BERT): 0.5164363667857123
- Combined Prediction Score: 0.7426432536417072
- Mean Citation Score: 249.400688
- Max Citation Score: 274.87634
- Similarity Product: 172.75713768675686

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test